EEli Lilly logo

SEC EDGAR - Form 4 insider activity

Eli Lilly $LLY

Pharma - 4 filings indexed by Nortis

Nortis signal thesis

Cluster activity detected. Review whether the filings are open-market trades or routine compensation events.

0

OM buys - 90d

0

OM sells - 90d

4

Routine filings

4

Cluster filings

$15.9K

Largest trade

15/100

Avg signal score

Filing tape

Recent filings

Last 30d: 4
Grant / AwardCLUSTERRoutine 15/100
filed 2026-07-21
SGBoard

Sulzberger Gabrielle - Director - $5.0K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-07-21
LRBoard

LUCIANO JUAN R - Director - $15.9K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-07-21
FEBoard

Fyrwald J Erik - Director - $9.9K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-07-21
ARBoard

Alvarez Ralph - Director - $12.4K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing